Infant Bacterial Therapeutics AB (publ)

Share · SE0008015259 (XSTO)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Infant Bacterial Therapeutics AB (publ)

No Price

Closing Price XSTO 29.04.2026: 55,90 SEK

29.04.2026 14:52

Current Prices from Infant Bacterial Therapeutics AB (publ)

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	IBT-B.ST	SEK	29.04.2026 14:52	55,90 SEK	0,40 SEK +0,72 %

Share Float & Liquidity

Free Float 86,24 %

Shares Float 11,23 M

Shares Outstanding 13,02 M

Company Profile for Infant Bacterial Therapeutics AB (publ) Share

Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe disease in infants. The company was founded in 2013 and is based in Stockholm, Sweden.